Cargando…

Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials

BACKGROUND: Data collection for economic evaluation alongside clinical trials is burdensome and cost-intensive. Limiting both the frequency of data collection and recall periods can solve the problem. As a consequence, gaps in survey periods arise and must be filled appropriately. The aims of our st...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidl, Hildegard, Meisinger, Christa, Wende, Rupert, Holle, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520702/
https://www.ncbi.nlm.nih.gov/pubmed/22978572
http://dx.doi.org/10.1186/1472-6963-12-318
_version_ 1782252811964121088
author Seidl, Hildegard
Meisinger, Christa
Wende, Rupert
Holle, Rolf
author_facet Seidl, Hildegard
Meisinger, Christa
Wende, Rupert
Holle, Rolf
author_sort Seidl, Hildegard
collection PubMed
description BACKGROUND: Data collection for economic evaluation alongside clinical trials is burdensome and cost-intensive. Limiting both the frequency of data collection and recall periods can solve the problem. As a consequence, gaps in survey periods arise and must be filled appropriately. The aims of our study are to assess the validity of incomplete cost data collection and define suitable resource categories. METHODS: In the randomised KORINNA study, cost data from 234 elderly patients were collected quarterly over a 1-year period. Different strategies for incomplete data collection were compared with complete data collection. The sample size calculation was modified in response to elasticity of variance. RESULTS: Resource categories suitable for incomplete data collection were physiotherapy, ambulatory clinic in hospital, medication, consultations, outpatient nursing service and paid household help. Cost estimation from complete and incomplete data collection showed no difference when omitting information from one quarter. When omitting information from two quarters, costs were underestimated by 3.9% to 4.6%. With respect to the observed increased standard deviation, a larger sample size would be required, increased by 3%. Nevertheless, more time was saved than extra time would be required for additional patients. CONCLUSION: Cost data can be collected efficiently by reducing the frequency of data collection. This can be achieved by incomplete data collection for shortened periods or complete data collection by extending recall windows. In our analysis, cost estimates per year for ambulatory healthcare and non-healthcare services in terms of three data collections was as valid and accurate as a four complete data collections. In contrast, data on hospitalisation, rehabilitation stays and care insurance benefits should be collected for the entire target period, using extended recall windows. When applying the method of incomplete data collection, sample size calculation has to be modified because of the increased standard deviation. This approach is suitable to enable economic evaluation with lower costs to both study participants and investigators. TRIAL REGISTRATION: The trial registration number is ISRCTN02893746
format Online
Article
Text
id pubmed-3520702
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35207022012-12-14 Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials Seidl, Hildegard Meisinger, Christa Wende, Rupert Holle, Rolf BMC Health Serv Res Research Article BACKGROUND: Data collection for economic evaluation alongside clinical trials is burdensome and cost-intensive. Limiting both the frequency of data collection and recall periods can solve the problem. As a consequence, gaps in survey periods arise and must be filled appropriately. The aims of our study are to assess the validity of incomplete cost data collection and define suitable resource categories. METHODS: In the randomised KORINNA study, cost data from 234 elderly patients were collected quarterly over a 1-year period. Different strategies for incomplete data collection were compared with complete data collection. The sample size calculation was modified in response to elasticity of variance. RESULTS: Resource categories suitable for incomplete data collection were physiotherapy, ambulatory clinic in hospital, medication, consultations, outpatient nursing service and paid household help. Cost estimation from complete and incomplete data collection showed no difference when omitting information from one quarter. When omitting information from two quarters, costs were underestimated by 3.9% to 4.6%. With respect to the observed increased standard deviation, a larger sample size would be required, increased by 3%. Nevertheless, more time was saved than extra time would be required for additional patients. CONCLUSION: Cost data can be collected efficiently by reducing the frequency of data collection. This can be achieved by incomplete data collection for shortened periods or complete data collection by extending recall windows. In our analysis, cost estimates per year for ambulatory healthcare and non-healthcare services in terms of three data collections was as valid and accurate as a four complete data collections. In contrast, data on hospitalisation, rehabilitation stays and care insurance benefits should be collected for the entire target period, using extended recall windows. When applying the method of incomplete data collection, sample size calculation has to be modified because of the increased standard deviation. This approach is suitable to enable economic evaluation with lower costs to both study participants and investigators. TRIAL REGISTRATION: The trial registration number is ISRCTN02893746 BioMed Central 2012-09-15 /pmc/articles/PMC3520702/ /pubmed/22978572 http://dx.doi.org/10.1186/1472-6963-12-318 Text en Copyright ©2012 Seidl et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Seidl, Hildegard
Meisinger, Christa
Wende, Rupert
Holle, Rolf
Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
title Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
title_full Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
title_fullStr Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
title_full_unstemmed Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
title_short Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
title_sort empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520702/
https://www.ncbi.nlm.nih.gov/pubmed/22978572
http://dx.doi.org/10.1186/1472-6963-12-318
work_keys_str_mv AT seidlhildegard empiricalanalysisshowsreducedcostdatacollectionmaybeanefficientmethodineconomicclinicaltrials
AT meisingerchrista empiricalanalysisshowsreducedcostdatacollectionmaybeanefficientmethodineconomicclinicaltrials
AT wenderupert empiricalanalysisshowsreducedcostdatacollectionmaybeanefficientmethodineconomicclinicaltrials
AT hollerolf empiricalanalysisshowsreducedcostdatacollectionmaybeanefficientmethodineconomicclinicaltrials